Health ❯ Healthcare

Personalized Medicine

Genetic Testing Targeted Therapy Targeted Therapies Treatment Strategies Biomarkers Patient Care Precision Medicine Cancer Treatment Immunotherapy Predictive Medicine Precision Oncology Tailored Treatments Treatment Approaches Therapeutics Treatment Decision-Making Genetics Treatment Options Risk Assessment Biotechnology Genomic Information Tailored Treatment Patient-Specific Treatments Preventive Strategies Biological Therapies Patient Outcomes mRNA Technology Cancer Research Intervention Strategies At-Home Testing Combination Therapy Therapeutic Strategies Treatment Costs Personalized Interventions Clinical Research Dietary Recommendations Treatment Plans Wearable Devices Health Strategies Predictive Models Smart Drugs Drug Targets Treatment Development Blood Tests Genetic Engineering Treatment Stratification Neoantigen Therapy Pharmacogenomics Immune Diseases Metabolic Rejuvenation Treatment Prediction Oncology Patient-Centric Care Cancer Therapies Medical Advice Modular Therapeutics Patient Screening Treatment Planning Disease Prevention Treatment Response AI in Medicine Preventive Care Targeted Drug Development AI in Healthcare Genomics Neoantigens Patient Consent Theranostics Gene Therapy Treatment Efficacy Gene Editing Obesity Consumer Health Genomic Medicine

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

Linked to dual GLP‑1/GIP targeting, tirzepatide showed larger average weight loss in trials with uncertain post‑treatment durability.

Gene Test Lets Many Over-40 Breast Cancer Patients Skip Chemotherapy

Insilico Medicine and Human Life Foundation Models Partner to Build AI Foundation Models for Longevity

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

Study Details VeloCD Blood Method to Predict Illness Trajectory

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

Large U.S. Study Validates BiliSeq Test That Nearly Doubles Bile Duct Cancer Detection

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

Study of 16p12.1 Families in Cell Shows Secondary Variants Shape Disease

gnomAD Adds Local Ancestry Frequencies to Improve Genetic Test Accuracy

EML4-ALK V3 Proves More Aggressive and Less Drug-Sensitive Than V1 in New Study

UC San Diego Reports First Anterior Cervical Surgery With Fully Personalized Implant

Study Links Early Puberty and Early Childbirth to Faster Aging, Higher Disease Risk

Optimized Graphene Oxide Nanocarrier Achieves Targeted Tumor Uptake, Paving Way for Theranostics

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Parkinson’s Onset Side Predicts Divergent Cognitive and Mental Health Trajectories

CrossNN AI Model Classifies Over 170 Cancer Types From Liquid Biopsies

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

H63D Variant in HFE Gene More Than Doubles Dementia Risk in Men